These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17265252)
1. [Priority for atypical antipsychotic drugs? Current studies clarify the issues]. Dose M Psychiatr Prax; 2007 Jan; 34(1):46-9. PubMed ID: 17265252 [No Abstract] [Full Text] [Related]
2. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Heinrichs RW Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745 [No Abstract] [Full Text] [Related]
4. First- and second-generation antipsychotics: learning from CUtLASS and CATIE. Tandon R; Carpenter WT; Davis JM Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642 [No Abstract] [Full Text] [Related]
5. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia. Vohora D Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473 [TBL] [Abstract][Full Text] [Related]
6. Lessons from each drug trial. Marder SR Am J Psychiatry; 2007 Mar; 164(3):375-6. PubMed ID: 17329457 [No Abstract] [Full Text] [Related]
7. The CATIE study and its implications for antipsychotic drug use. Janicak PG Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293 [No Abstract] [Full Text] [Related]
9. First- vs second-generation antipsychotic drugs in schizophrenia. Andrade C; Kharawala S Arch Gen Psychiatry; 2007 Aug; 64(8):978-9; author reply 979-80. PubMed ID: 17679643 [No Abstract] [Full Text] [Related]
10. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia. Citrome L Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940 [No Abstract] [Full Text] [Related]
11. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? Motlová L; Spaniel F; Höschl C; Balon R Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853 [TBL] [Abstract][Full Text] [Related]
12. How to manage in current treatment of schizophrenic patients. Loga S Psychiatr Danub; 2007 Dec; 19(4):359-61. PubMed ID: 18000489 [TBL] [Abstract][Full Text] [Related]
13. The costs of drugs for schizophrenia. Freedman R; Carpenter WT; Davis JM; Goldman HH; Tamminga CA; Thomas M Am J Psychiatry; 2006 Dec; 163(12):2029-31. PubMed ID: 17151146 [No Abstract] [Full Text] [Related]
14. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP]. Buis C; Gourion D; Vaiva G Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185 [No Abstract] [Full Text] [Related]
15. Do atypical antipsychotic agents have a role in the treatment of depression? Bailey KP J Psychosoc Nurs Ment Health Serv; 2003 Oct; 41(10):12-6. PubMed ID: 14571629 [No Abstract] [Full Text] [Related]
16. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies. Taylor DM; Smith L Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679 [TBL] [Abstract][Full Text] [Related]
17. [Reaction on 'typical and atypical antipsychotics: is there a difference in their influence on neurocognition?']. van Oeffelt T Tijdschr Psychiatr; 2011; 53(4):255-6; author reply 256-7. PubMed ID: 21506082 [No Abstract] [Full Text] [Related]
18. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216 [TBL] [Abstract][Full Text] [Related]